Results 161 to 170 of about 3,514,109 (209)
Some of the next articles are maybe not open access.

Benefits Analysis—A Robust Assessment Approach

Journal of the Operational Research Society, 2004
Summary: Benefits Analysis has been evolving over the past decade from roots in multi-criteria analysis, causal mapping and multi-methodology. It has now reached a level of maturity such that it deserves to be treated as a method in its own right, and this paper seeks to document the method and provide guidance on its use.
openaire   +1 more source

Assessing the Benefits

1984
We started this book looking at the possible needs and uses of computers and we have continued looking at the way computers can be used effectively. If we can make the decision to use computers, then it should follow that we can assess the benefits after the event.
openaire   +1 more source

Benefit-Risk Assessment

1979
Those who organized the program for this symposium have, indeed, done a skillful job. Scientific presentations on previous days focused attention on exciting new technologies and their obvious- utilities. Speakers and discussants led us onto a mountain of expectation.
openaire   +1 more source

Risk-benefit assessment

2023
Jeljer Hoekstra   +2 more
openaire   +1 more source

Benefit Assessment in Germany

New England Journal of Medicine, 2010
Joerg, Hasford, Walter, Lehmacher
openaire   +2 more sources

Assessing Benefit in PoTS

2020
Assessing benefit in PoTS can be complex as it is defined not only on the basis of a postural heart rate change but also on symptoms. Symptoms may vary with time which adds complexity. Purely basing an assessment on a postural heart change does not provide the full picture however currently there are no validated questionnaires to assess for symptom ...
openaire   +1 more source

[Benefit assessment of drugs].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2017
In Germany, new drugs are subject to a benefit assessment at the time of their market access. This "early benefit assessment" is the method primarily used for the benefit assessment of pharmaceuticals in Germany. While for the authorization of a drug a positive risk-benefit ratio is sufficient, early benefit assessment examines whether the new drug has
Thomas, Kaiser   +2 more
openaire   +1 more source

Assessing consumer benefit

General Hospital Psychiatry, 1987
Emily Mumford, Herbert J. Schlesinger
openaire   +1 more source

Risk-Benefit Assessment

2013
Kristine M. Molina   +58 more
openaire   +1 more source

Home - About - Disclaimer - Privacy